Biocryst Pharmaceuticals INC (BCRX) SEC Filings — 2024
24 SEC filings for Biocryst Pharmaceuticals INC (BCRX) in 2024.
Filings
- Biocryst Pharmaceuticals INC SC 13G/A Filing — SC 13G/A · Nov 7, 2024
- BioCryst Pharmaceuticals Files Q3 2024 10-Q — 10-Q · Nov 5, 2024
- BioCryst Pharmaceuticals Files 8-K — 8-K · Nov 4, 2024
- Biocryst Pharmaceuticals INC SC 13G/A Filing — SC 13G/A · Nov 4, 2024
- Biocryst Pharmaceuticals INC SC 13G/A Filing — SC 13G/A · Oct 17, 2024
- BioCryst Pharmaceuticals Files 8-K — 8-K · Oct 2, 2024
- BioCryst Pharmaceuticals Files 8-K — 8-K · Sep 30, 2024
- Biocryst Pharmaceuticals INC SC 13G/A Filing — SC 13G/A · Sep 10, 2024
- BioCryst Pharmaceuticals Files 10-Q for Q2 2024 — 10-Q · Aug 6, 2024
- BioCryst Pharmaceuticals Files 8-K on Financials — 8-K · Aug 5, 2024
- BioCryst Appoints New Chief Medical Officer — 8-K · Jun 13, 2024
- BioCryst Pharmaceuticals Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 7, 2024
- BioCryst Pharmaceuticals Files 8-K on Financials — 8-K · May 6, 2024
- BioCryst Pharmaceuticals Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 25, 2024
- Biocryst Pharmaceuticals Files Proxy Materials — DEFA14A · Apr 25, 2024
- BioCryst Pharmaceuticals Files 2023 Annual Report on Form 10-K — 10-K · Feb 27, 2024
- BioCryst Pharmaceuticals Files 8-K on Financial Results — 8-K · Feb 26, 2024
- Biocryst Pharmaceuticals INC SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Biocryst Pharmaceuticals INC SC 13G Filing — SC 13G · Feb 14, 2024
- Vanguard Discloses 12.96% Stake in BioCryst Pharma — SC 13G/A · Feb 13, 2024
- BlackRock Amends BioCryst Stake: Passive Investment Update — SC 13G/A · Jan 24, 2024
- State Street Corp. Amends BioCryst Pharma Stake Filing — SC 13G/A · Jan 24, 2024
- BioCryst Amends Bylaws, Easing Director Removal Process — 8-K · Jan 18, 2024
- BioCryst 8-K Signals New Financial Disclosures on Jan 5 — 8-K · Jan 8, 2024